Evidence map›Paper›PMID 16716599›Full record

ReviewCritical reviews in oncology/hematology2006

The growth factor independence-1 transcription factor: new functions and new insights.

Avedis Kazanjian, Eleanore A Gross, H Leighton Grimes

Abstract readReview
In one paragraph

Review in Critical reviews in oncology/hematology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A novel regulatory gene promotes novel cell fate by suppressing ancestral fate in the sea anemoneProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Molecular cancer research : MCR · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Avedis KazanjianInstitute for Cellular Therapeutics, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Eleanore A Gross
H Leighton Grimes
University of Louisville · US

Funding

Molecular Mechanism of Severe Congenital NeutropeniaR01HL079574 · NHLBI · UNIVERSITY OF LOUISVILLE · PI GRIMES, H. LEIGHTON · 2004 to 2009
$2.4M
A Molecular Basis for Neuroendocrine CarcinogenesisR01CA112405 · NCI · UNIVERSITY OF LOUISVILLE · PI GRIMES, H. LEIGHTON · 2005 to 2009
$1.2M
Transcriptional repression in leukemiaR01CA105152 · NCI · UNIVERSITY OF LOUISVILLE · PI GRIMES, H. LEIGHTON · 2004 to 2007
$1.0M
NCI NIH HHS CA105152NCI NIH HHS CA112405NCI NIH HHS R01 CA105152NCI NIH HHS R01 CA112405NHLBI NIH HHS HL079574NHLBI NIH HHS R01 HL079574
6 · The paper itself

Abstract

The growth factor independence-1 (Gfi1) transcription factor is required for proper development of neuroendocrine cells, sensory neurons, and blood. Patients with mutations in Gfi1 exhibit severe congenital neutropenia (SCN) or non-immune chronic idiopathic neutropenia of adults. Gfi1 was initially described as an oncoprotein that mediates tumor progression in a mouse model of leukemia; however, recent data suggest that Gfi1 may act as either an oncogene or an anti-proliferative tumor suppressor gene depending on the cell type. Here we review the latest literature on Gfi1, and emphasize its role in the hematopoietic, sensory and neuroendocrine systems.

Indexed as

AnimalsDNA-Binding ProteinsHematopoiesisHumansMiceNeurons, AfferentNeurosecretory SystemsNeutropeniaOncogene ProteinsOrgan SpecificityTranscription FactorsTumor Suppressor ProteinsDNA-Binding ProteinsGFI1 protein, humanGfi1 protein, mouseOncogene ProteinsTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID16716599
PMCPMC2830489
OpenAlexW2026916779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.